Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Quant Biomarkers logo — Quant Biomarkers is a data-driven biomedical and longevityte...

Quant Biomarkers

Quant Biomarkers is a data-driven biomedical and longevitytech company.

Founded 2021 Switzerland Basel, Switzerland 5 employees Biotechnology, Marketing

General Information

Company Name Quant Biomarkers
Founded Year 2021
Location Switzerland Basel, Switzerland +1
Employees 5
Industries Biotechnology, Marketing
Social

Get notified when Quant Biomarkers moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Quant Biomarkers

Quant Biomarkers is a data-driven biomedical and Longevitytech company focused on the analysis and validation of longitudinal clinical data and personalized biomarker assessment to support intervention decisions and Longevity Medicine therapeutic modalities. The company, founded in 2021, operates within the biotechnology and marketing industries. Quant Biomarkers aims to drive effective clinical care by leveraging rapidly advanced biological science and technology for informed clinical decisions. As of now, there is no public information available regarding the headquarters, last investment, or investors of the company.

Taxonomy: Biomedical Data Analysis, Longevity Technology, Personalized Biomarkers Assessment, Longevity Medicine, AI and Tech-Powered Platforms, Biomarkers of Human Longevity, Oncology Biomarker Development, Investment De-risking, R&D Acceleration, IP Acquisition, Precision Health Products, Longevity Preventive Medicine, Financial and Analytical Services

No funding data available for Quant Biomarkers yet.

Get notified when Quant Biomarkers raises funding

Quant Biomarkers Alternatives & Competitors

Quant Biomarkers vs
Combinostics
Combinostics Finland

Using a combination of science and AI technology, we aim to improve the lives of patients with neuro...

Series A
11 employees
Enterprise Software, Health Care
Quant Biomarkers vs
Deep Longevity
Deep Longevity Hong Kong S.a.r.

Using Science of Longevity to Improve Healthspan & Lifespan

Series A
7 employees
Biotechnology, Health Care
Quant Biomarkers vs
Atturos Ltd
Atturos Ltd Ireland

Developing new advanced diagnostic solutions to help patients make better decisions.

6 employees
Health Care

FAQ About Quant Biomarkers

Quant Biomarkers is a data-driven biomedical and longevitytech company.
Quant Biomarkers was founded in 2021.
Quant Biomarkers is headquartered in Basel, Switzerland.
Quant Biomarkers operates in the following industries: Biotechnology, Marketing.
Quant Biomarkers has approximately 5 employees.
Top alternatives and competitors to Quant Biomarkers include Combinostics, Deep Longevity, Atturos Ltd, Nucleai, Brainomix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Quant Biomarkers and Combinostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Quant Biomarkers and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes